Summary
Lenacapavir is an antiretroviral medication used to treat HIV/AIDS, approved by the U.S. Food and Drug Administration for the treatment of HIV-1 infection in heavily treatment-experienced adults with multi-drug resistant HIV-1 infection.
1
2
3
It works by interfering with capsid-mediated nuclear uptake of preintegration complexes and impairing virion production, inhibiting viral replication at both early and late stages of the life cycle.
4
1
According to
See more results on Neeva
Summaries from the best pages on the web
Summary
Lenacapavir is a first-in-class inhibitor of HIV-1 capsid function. 5 By interfering with capsid-mediated nuclear uptake of preintegration complexes and impairing virion production, lenacapavir inhibits viral replication at both early and late stages of the life cycle
Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 ...
nejm.org
Summary
Lenacapavir , sold under the brand name Sunlenca, is an antiretroviral medication used to treat HIV/AIDS. It is taken by mouth or by subcutaneous injection.
Lenacapavir - Wikipedia
wikipedia.org
Summary
(Nasdaq: GILD) today announced that Sunlenca ® (lenacapavir), in combination with other antiretroviral(s) (ARV), has been granted approval by the U.S. Food and Drug Administration (FDA) for the treatment of HIV-1 infection in heavily treatment-experienced (HTE) adults with multi-drug resistant (MDR) HIV-1 infection
Sunlenca® (lenacapavir) Receives FDA Approval as a First-in-Class ...
gilead.com
Lenacapavir oral comes as a tablet to take by mouth. It is usually taken with or without food once a day for the first two days before starting lenacapavir injection.…
Lenacapavir Oral: MedlinePlus Drug Information
medlineplus.gov
Summary
Today, the U.S. Food and Drug Administration approved Sunlenca (lenacapavir), a new type of antiretroviral medication for adult patients living with human immunodeficiency virus type 1 (HIV-1), whose HIV infections cannot be successfully treated with other available treatments due to resistance, intolerance, or safety considerations
FDA Approves New HIV Drug for Adults with Limited Treatment Options
fda.gov
